about
Isoniazid-associated hepatitis--serum enzyme determinations and histologic features.Successful liver transplantation for isoniazid-induced hepatic failure--a case reportAdverse reactions to first-line antituberculosis drugs.Optic neuritis occurring with anti-tumour necrosis factor alpha therapy.Screening indochinese refugee patients: result of 192 cases.Pulmonary infiltrates and fever induced by isoniazid.Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.Multiple etiologies of axonal sensory motor polyneuropathy in a renal transplant recipient: a case report.Encephalopathy secondary to isoniazid in patients on hemodialysisAcute diffuse interstitial nephritis related to chemotherapy of tuberculosispH-Responsive Isoniazid-Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in MiceFlow Cytometric Characterization of Antigen-Specific T Cells Based on RNA and Its Advantages in Detecting Infections and Immunological Disorders.Isoniazid causing pleural effusion.Pure red blood cell aplasia and isoniazid useAntituberculosis therapy-induced acute liver failure: magnitude, profile, prognosis, and predictors of outcome.An unusual case of isoniazid toxicity.Vasculitis with alclofenac therapy.Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against H37Rv strain
P2860
Q28338131-A63360C7-9C65-44F7-854C-BC3C9754C44FQ28369679-9899528A-B77E-4E88-A31A-A46C394B79A3Q34497890-594988E9-EC99-49EB-8773-85A4F88C4804Q35954593-3A225C29-0262-46BD-A8D9-083113183508Q36657141-473968E7-4D46-44EB-9CDE-8BE60C86DC30Q36723878-427B4750-D5A9-40BE-B295-302FE025B0D6Q38099248-80CB300E-EED4-4C21-862E-47CDB0D3D4C3Q39353215-E1114F94-EA0E-4BAF-AC4F-4811E8D9F4FCQ39712897-3206025F-5D58-4B92-9387-BF0F87564B75Q40946933-6F229EF6-E8CF-4890-B957-A21CF695B294Q41099486-1F96E6F7-E2F7-49CF-8B42-8DEC100EC739Q41307773-7F63B66F-702C-41CE-88B4-AF1885A5333AQ42577522-582381F6-F723-400F-BFBF-6BC635EDE6D8Q42831943-2F666D5D-8F17-4CA6-8C0D-F9F90C2C241FQ43145214-4EA94801-776F-40AC-8E8E-A7FC4006E04AQ48334726-E7018F56-B890-47FC-9E93-0F30E12FA9BBQ53882203-A607D449-4B22-4A9D-8420-E7262C40C555Q56525852-C53D512D-A223-4209-B0DF-3AEC081B0B8F
P2860
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Isoniazid: a review with emphasis on adverse effects.
@en
Isoniazid: a review with emphasis on adverse effects.
@nl
type
label
Isoniazid: a review with emphasis on adverse effects.
@en
Isoniazid: a review with emphasis on adverse effects.
@nl
prefLabel
Isoniazid: a review with emphasis on adverse effects.
@en
Isoniazid: a review with emphasis on adverse effects.
@nl
P356
P1433
P1476
Isoniazid: a review with emphasis on adverse effects.
@en
P2093
A L Goldman
S S Braman
P356
10.1378/CHEST.62.1.71
P407
P577
1972-07-01T00:00:00Z